News | September 17, 2014

After controversial withdrawal from Southampton General Hospital, Ashya King begins treatment in Prague

Pediatric Brain Tumor Patient From the U.K. Undergoes First Treatment of Proton Therapy

Ashya King's prescribed treatment plan for proton therapy


September 17, 2014 — Five-year-old Ashya King, the brain tumor patient whose case made headlines in Europe after his parents unlawfully took him from his hospital in Southampton, England, against the advice of doctors, began undergoing his prescribed treatment plan for proton therapy this week.

King was previously under the care of Southampton General Hospital for treatment of medulloblastoma. After unsatisfaction with the hospital’s treatment plan, King’s father sought more effective approaches through the Internet and came upon proton therapy. When the hospital refused to attempt it on King, his parents fled the United Kingdom to find a hospital that would, sparking a controversial debate.

The boy is now under the care of Motol University Hospital, where he is staying while undergoing treatment at the Proton Therapy Centre Czech in Prague. The overall course of treatment will take place over 30 visits; the first 13 will be to deliver irradiation to the entire tumor area—including the spinal cord, to ensure it is not spreading via cerebrospinal fluid—while the following 17 will be to treat just the tumor volume.

“There is a 70 to 80 percent survival rate for the condition such as the one Ashya has, and there is now every reason to hope that he will make a full recovery,” said his attending physician, Barbora Ondrová, M.D.

To illustrate the differences between proton therapy and conventional radiation therapy, the specialists at Proton Therapy Centre Czech drew up treatment plans for both techniques. In King’s case, it is necessary to apply the highest possible dose into the tumor but protect the tissue around it as much as possible. Vital structures to be protected include the heart, lung, liver and intestines. This means decreasing the risk of developing cardiovascular disorders, breathing disorders or metabolic disorders, and better protection of the swallowing functions and normal food intake.

For more information: www.ptc.cz


Related Content

News | Radiation Therapy

April 18, 2024 — Accuray Incorporated announced that as part of its commitment to advancing patient care the company has ...

Time April 18, 2024
arrow
News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
Subscribe Now